Re: FDA approves Pfizer nerve pain drug ~ Lyrica
From: Don Kirkman (donkirk_at_covad.net)
Date: 01/04/05
- Next message: Anon: "LDL of 323!"
- Previous message: Don Kirkman: "Re: FDA: 139,000 people had heart attacks that may be linked to Vioxx"
- In reply to: Sharon Hope: "Re: FDA approves Pfizer nerve pain drug ~ Lyrica"
- Next in thread: Sharon Hope: "Re: FDA approves Pfizer nerve pain drug ~ Lyrica"
- Reply: Sharon Hope: "Re: FDA approves Pfizer nerve pain drug ~ Lyrica"
- Messages sorted by: [ date ] [ thread ]
Date: Tue, 04 Jan 2005 11:47:23 -0800
It seems to me I heard somewhere that Sharon Hope wrote in article
<qinCd.745407$mD.158002@attbi_s02>:
>You are ignorant of the facts in this case.
>Dr. Golomb does not practice at the university. Her practice is at the VA
>Medical Center.
>A renaissance woman, she is the NIH Principal Investigator for the NIH
>Statin Study (which accepts no drug company funding), and concurrently she
>is teaching at two universities, and a RAND researcher. She is also the US
>DOD's expert on Gulf War Syndrome.
>
>Her credentials are readily accessible (CV below). What are your
>credentials?
My only point had nothing to do with credentials. I may have been in
error about the location of her principal practice, though she is an
Assistant Professor of Medicine at the University of California-San
Diego.
To restate my point, it is not at all clear what Dr. Golomb's 15% figure
is measuring. I didn't find it in reports of her publications or
presentations I found in Google, and the only clear statement of that
figure is "Dr. Golomb has found that 15 percent of statin patients
develop some cognitive side effects.{22}" contained in a web page I
believe you are familiar with, since it discusses your husband's case:
http://www.mercola.com/2004/jul/24/statin_drugs.htm.
Reference 22 says in its entirety "22. Email communication, Beatrice
Golomb, July 10, 2003."
Perhaps you have a documented source for that figure?
As we were discussing almost a year ago:
"'Although the patient data in the NIH study is still secret, Dr. Golomb
says that among other patients she has seen, about 15% have developed
some cognitive problem related to statin use. Even so, notes Dr. Golomb,
'there are still people who are persuaded ... that there are no
cognitive effects from statins.'
"Note that the 15% is not from the NIH study but is Dr. Golomb's
estimate from her own practice. Also note that 15% could be three
patients out of twenty, and that Dr. Golomb's clientele may not be
typical, since she is associated with a university."
-- Don "I do not feel obliged to believe that the same God who has endowed us with senses, reason, and intellect has intended us to forgo their use. --Galileo Galilei
- Next message: Anon: "LDL of 323!"
- Previous message: Don Kirkman: "Re: FDA: 139,000 people had heart attacks that may be linked to Vioxx"
- In reply to: Sharon Hope: "Re: FDA approves Pfizer nerve pain drug ~ Lyrica"
- Next in thread: Sharon Hope: "Re: FDA approves Pfizer nerve pain drug ~ Lyrica"
- Reply: Sharon Hope: "Re: FDA approves Pfizer nerve pain drug ~ Lyrica"
- Messages sorted by: [ date ] [ thread ]
Relevant Pages
|